Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

cDNA cloning and chromosomal mapping of a predicted coiled-coil proline-rich protein immunogenic in meningioma patients.

Heckel D, Brass N, Fischer U, Blin N, Steudel I, Türeci O, Fackler O, Zang KD, Meese E.

Hum Mol Genet. 1997 Nov;6(12):2031-41.

PMID:
9356211
2.

Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII.

Wikstrand CJ, McLendon RE, Friedman AH, Bigner DD.

Cancer Res. 1997 Sep 15;57(18):4130-40.

3.

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity.

Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kündig T, Hengartner H.

Immunol Rev. 1997 Apr;156:199-209. Review.

PMID:
9176709
4.

Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma.

Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW, Meese E.

Hum Mol Genet. 1997 Jan;6(1):33-9.

PMID:
9002667
5.

Twelve amplified and expressed genes localized in a single domain in glioma.

Fischer U, Meltzer P, Meese E.

Hum Genet. 1996 Nov;98(5):625-8.

PMID:
8882887
6.

Tumor antigens in astrocytic gliomas.

Kurpad SN, Zhao XG, Wikstrand CJ, Batra SK, McLendon RE, Bigner DD.

Glia. 1995 Nov;15(3):244-56. Review.

PMID:
8586461
7.

Human neoplasms elicit multiple specific immune responses in the autologous host.

Sahin U, Türeci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M.

Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11810-3.

8.

Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report.

Bigner DD, Brown M, Coleman RE, Friedman AH, Friedman HS, McLendon RE, Bigner SH, Zhao XG, Wikstrand CJ, Pegram CN, et al.

J Neurooncol. 1995;24(1):109-22.

PMID:
8523067
9.

Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses.

Schröck E, Thiel G, Lozanova T, du Manoir S, Meffert MC, Jauch A, Speicher MR, Nürnberg P, Vogel S, Jänisch W, et al.

Am J Pathol. 1994 Jun;144(6):1203-18.

10.

Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.

Lang FF, Miller DC, Koslow M, Newcomb EW.

J Neurosurg. 1994 Sep;81(3):427-36.

PMID:
8057151
11.

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.

Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, Huang HJ.

Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7727-31.

12.

Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

Disis ML, Calenoff E, McLaughlin G, Murphy AE, Chen W, Groner B, Jeschke M, Lydon N, McGlynn E, Livingston RB, et al.

Cancer Res. 1994 Jan 1;54(1):16-20.

13.

"A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Feinberg AP, Vogelstein B.

Anal Biochem. 1984 Feb;137(1):266-7. No abstract available.

PMID:
6329026
14.

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B.

Proc Natl Acad Sci U S A. 1987 Oct;84(19):6899-903.

15.

Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

Mitchell PJ, Tjian R.

Science. 1989 Jul 28;245(4916):371-8. Review.

PMID:
2667136
16.

Circulating antibodies against c-myc oncogene product in sera of colorectal cancer patients.

Ben-Mahrez K, Sorokine I, Thierry D, Kawasumi T, Ishii S, Salmon R, Kohiyama M.

Int J Cancer. 1990 Jul 15;46(1):35-8.

PMID:
2142141
17.

Presence of circulating anti-c-myb oncogene product antibodies in human sera.

Sorokine I, Ben-Mahrez K, Bracone A, Thierry D, Ishii S, Imamoto F, Kohiyama M.

Int J Cancer. 1991 Mar 12;47(5):665-9.

PMID:
2004847
18.

Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989.

Prados MD, Gutin PH, Phillips TL, Wara WM, Larson DA, Sneed PK, Davis RL, Ahn DK, Lamborn K, Wilson CB.

Int J Radiat Oncol Biol Phys. 1992;23(1):3-8.

PMID:
1572829
19.

p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.

Frankel RH, Bayona W, Koslow M, Newcomb EW.

Cancer Res. 1992 Mar 15;52(6):1427-33.

20.

p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.

Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.

Cancer Res. 1992 Feb 1;52(3):674-9.

Supplemental Content

Support Center